gip glp 1 The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Potential of a glucagon‐like peptide‐1

Patients often ask what happens if you miss a GLP-1 dose, but with patches, the issue is bigger, they dont deliver the drug at all

10.1056/NEJMoa2410027

IQVIA blog, December 2024: GLP-1s and digital support: A winning combination

In head-to-head trials, tirzepatide 15mg vs semaglutide 1mg in type 2 diabetes showed greater A1c drop (~2.0% vs 1.4%) and greater weight loss (~11 kg vs 5 kg) ( [138] )

This therapy activates two hormonal pathways to help you feel fuller longer, reduce cravings, and improve your bodys ability to manage blood sugar after meals

Is It Normal to Feel Headache or Fatigue On Semaglutide or Tirzepatide